KNILONAT 150MG CAPS 10 s BS STRIP

KNILONAT 150MG CAPS 10 s BS STRIP Specification

Dosage Form
Capsule

Indication
Chronic Myeloid Leukemia (CML)

Salt Composition
Nilotinib 150 mg

Feature
Anti-cancer, targeted therapy

Ingredients
Nilotinib Hydrochloride Monohydrate

Application
Oncology Treatment

Physical Color/Texture
Yellow opaque/Hard gelatin capsule

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 months

Blister Type
Alu-Alu Strip

Strength
150 mg

Administration Route
Oral

Packing
10 capsules per strip

Prescription
Required

KNILONAT 150MG CAPS 10 s BS STRIP Trade Information

Minimum Order Quantity
100 Boxes

Supply Ability
5000 Boxes Per Month

Delivery Time
10 Days

About KNILONAT 150MG CAPS 10 s BS STRIP

Take advantage of our Price Cut on KNILONAT 150MG CAPS 10 s BS STRIP-crafted with the finest commitment for oncology professionals and patients. Each strip contains 10 heroic capsules, each boasting 150 mg of Nilotinib Hydrochloride Monohydrate, presented in a grand Alu-Alu blister for enduring protection. This anti-cancer targeted therapy is indicated for Chronic Myeloid Leukemia (CML) and requires a prescription. Purchase this trusted solution, proudly supplied, exported, and traded from India's premier medical hub. Your journey to effective cancer management starts here.

Competitive Advantages and Uses of KNILONAT 150MG CAPS 10 s BS STRIP

KNILONAT 150MG CAPS deliver specific, targeted therapy for Chronic Myeloid Leukemia (CML), ensuring optimal treatment outcomes. Produced by top Indian exporters, suppliers, and wholesalers, these capsules stand out for their grand quality and heroic efficacy in oncology care. Their Alu-Alu blister packaging offers protection against moisture, extending product shelf life to 24 months. With a prescription, patients benefit from the finest anti-cancer formulation aimed at reliable results and broad adaptability in cancer treatment protocols.

Sample Availability and Market Excellence for KNILONAT 150MG CAPS 10 s BS STRIP

Samples of KNILONAT 150MG CAPS 10 s BS STRIP are readily available to approved buyers to facilitate informed purchase decisions. Our main export markets drop-off across Asia, Africa, and the Middle East, with a growing domestic rate of adoption in India. We ensure quick dispatch of all orders, maintaining product integrity through proper storage and speedy logistics. Our customer-oriented export and supply chain model guarantees efficient delivery to hospitals, clinics, and pharmacies worldwide.

FAQ's of KNILONAT 150MG CAPS 10 s BS STRIP:

Q: How should KNILONAT 150MG CAPS be administered?

A: KNILONAT 150MG CAPS are designed for oral administration. It is recommended that they be taken exactly as prescribed by a healthcare professional to ensure maximum therapeutic benefit.

Q: What is the primary indication for using KNILONAT 150MG CAPS?

A: The primary use of KNILONAT 150MG CAPS is for the treatment of Chronic Myeloid Leukemia (CML) as part of a targeted anti-cancer therapy regimen.

Q: When can I expect my order of KNILONAT 150MG CAPS to be dispatched?

A: We prioritize quick dispatch and aim to process orders promptly; specific timelines may vary depending on the delivery location and order volume.

Q: Where is KNILONAT 150MG CAPS primarily exported and supplied?

A: KNILONAT 150MG CAPS are mainly exported to markets across Asia, Africa, and the Middle East, with a strong presence in India's domestic healthcare sector as well.

Q: What are the storage instructions for KNILONAT 150MG CAPS?

A: KNILONAT 150MG CAPS should be stored below 30C and protected from moisture to maintain their integrity and effectiveness throughout their 24-month shelf life.

Q: How does KNILONAT 150MG CAPS offer a competitive advantage in oncology treatment?

A: By combining targeted therapy with robust packaging and consistent supply, KNILONAT 150MG CAPS ensure reliable cancer care, supporting both healthcare professionals and patients in achieving optimal results.

Tell us about your requirement